Aarti Pharmalabs Ltd (AARP)

Currency in INR
867.25
+2.05(+0.24%)
Closed·
AARP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
859.50879.40
52 wk Range
585.00946.10
Key Statistics
Bid/Ask
864.45 / 867.25
Prev. Close
865.2
Open
866
Day's Range
859.5-879.4
52 wk Range
585-946.1
Volume
343.72K
Average Volume (3m)
586.63K
1-Year Change
-0.339%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AARP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
740.00
Downside
-14.67%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Aarti Pharmalabs Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 740.00
(-14.67% Downside)

Earnings

Latest Release
Aug 07, 2026
EPS / Forecast
8.39 / --
Revenue / Forecast
5.36B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 22.56%
Dividend Yield
0.40%
Industry Median 0.67%
Annualized payout
3.50
Paid unevenly
5-Years Growth
-
Growth Streak

AARP Income Statement

Compare AARP to Peers and Sector

Metrics to compare
AARP
Peers
Sector
Relationship
P/E Ratio
38.7x36.8x−0.4x
PEG Ratio
−1.650.830.00
Price/Book
3.7x3.5x2.6x
Price / LTM Sales
4.0x3.7x3.1x
Upside (Analyst Target)
−14.4%7.9%49.0%
Fair Value Upside
Unlock−1.6%7.0%Unlock

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates, such as xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. It serves pharmaceutical, nutraceutical, and beverage industries. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Employees
2421
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.92M5.43%4.16B
Other Institutional Investors
30.29M33.42%25.61B
Public Companies & Retail Investors
55.44M61.16%46.87B
Total
90.66M100.00%76.64B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Life Insurance Corporation of India5.28%4,782,4524,043,085
Anushakti Enterprise Private Limited3.30%2,992,9502,530,240

People Also Watch

245.62
AEQU
-0.75%
3,810.60
SASE
-2.37%
2,189.60
AVAL
-5.56%
1,234.00
SUDP
+0.25%

FAQ

What Is the Aarti Pharmalabs (AARP) Stock Price Today?

The Aarti Pharmalabs stock price today is 867.25 INR.

What Stock Exchange Does Aarti Pharmalabs Trade On?

Aarti Pharmalabs is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Aarti Pharmalabs?

The stock symbol for Aarti Pharmalabs is "AARP."

Does Aarti Pharmalabs Pay Dividends? What’s The Current Dividend Yield?

The Aarti Pharmalabs dividend yield is 0.4%.

What Is the Aarti Pharmalabs Market Cap?

As of today, Aarti Pharmalabs market cap is 78.62B INR.

What Is Aarti Pharmalabs's Earnings Per Share (TTM)?

The Aarti Pharmalabs EPS (TTM) is 22.56.

From a Technical Analysis Perspective, Is AARP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Aarti Pharmalabs Stock Split?

Aarti Pharmalabs has split 0 times.

How Many Employees Does Aarti Pharmalabs Have?

Aarti Pharmalabs has 2421 employees.

What is the current trading status of Aarti Pharmalabs (AARP)?

As of Sep 02, 2026, Aarti Pharmalabs (AARP) is trading at a price of 867.25 INR, with a previous close of 865.20 INR. The stock has fluctuated within a day range of 859.50 INR to 879.40 INR, while its 52-week range spans from 585.00 INR to 946.10 INR.

What Is Aarti Pharmalabs (AARP) Price Target According to Analysts?

The average 12-month price target for Aarti Pharmalabs is 740.00 INR, with a high estimate of 740 INR and a low estimate of 740 INR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -14.67% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.